Nirrin Technologies
Billerica, US · Founded 2017 · Delaware corporation · 1 known investors
Find your way into Nirrin Technologies
162 people in our graph share verified history with the Nirrin Technologies team — schools, employers, funds. One of them is your warm intro.
Whitney Haring-Smithunlockedknows Jonathan Hartmann · together at Axsun Technologies (overlapped)
×2knows the team · via Sofregen
knows the team · via Nirrin Technologies
×4knows the team · via St. Lawrence University
×4knows the team · via Xerox Corporation
Nirrin builds optical instruments and analytics software for bioprocess teams to generate measurement data across development and manufacturing workflows. Its systems are designed for deployment in regulated biopharma production and quality environments.
Founders & leadership
BH
Bryan HassellinChief Executive Officer
JH
Jonathan HartmanninMember Board of DirectorsJonathan Hartmann is a healthcare technology executive who previously served as President and CEO of EvoEndo and has held general management, sales, marketing, and business development roles across the medical device industry. He holds a B.S. from St. Lawrence University and an MBA from Harvard Business School.
JC
Board
DS
DM
MG
Matthew GunnisonBoard director
DH
Investors · 1
Reported raises · per SEC filings
Form D private placements$20M disclosed across 3 of 4 rounds · 2021–2026
▶$6.7MraisedJun 2026 · 23 investors · BiotechnologyRule 506(b)
▶$6.7MraisedJun 2026 · 23 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Bryan HassellExecutive Officer
- David SeldinDirector
- David MichaelDirector
- Matthew GunnisonDirector
- Offering amount
- $9.7M
- Amount sold
- $6.7M
- Proceeds to insiders
- $241K
- First sale
- Sep 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.8MraisedFeb 2024 · 20 investors · BiotechnologyRule 506(b)
▶$4.8MraisedFeb 2024 · 20 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Debrah HermanExecutive Officer
- David Carr MichaelDirector
- Matthew GunnisonDirector
- Gregory CresenziExecutive Officer
- David Michael SeldinDirector
- Offering amount
- $6M
- Amount sold
- $4.8M
- First sale
- Feb 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$8.5MraisedOct 2021 · 1 investors · BiotechnologyRule 506(b)
▶$8.5MraisedOct 2021 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David Michael SeldinExecutive Officer, Director
- Debrah HermanExecutive Officer
- Jonathan HartmannExecutive Officer, Director
- David Carr MichaelDirector
- John C. HoDirector
- Offering amount
- $8.5M
- Amount sold
- $8.5M
- First sale
- Oct 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlap
Companies competing with Nirrin Technologies for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Nirrin Technologies has filed a notice of an exempt offering of securities to raise $9,711,196.00 in New Funding. - intelligence360intelligence360.news · Jul 2026Frequently asked questions
- What does Nirrin Technologies do?
- Nirrin builds optical instruments and analytics software for bioprocess teams to generate measurement data across development and manufacturing workflows. Its systems are designed for deployment in regulated biopharma production and quality environments.
- Who are Nirrin Technologies's investors?
- Nirrin Technologies's investors include Anzu Partners.
- How much funding has Nirrin Technologies raised?
- Nirrin Technologies has disclosed $20M raised across 3 of its 4 known rounds.
- Where is Nirrin Technologies headquartered?
- Nirrin Technologies is headquartered in Billerica, US.